Track the U.S. NeuroSurgical Holdings, Inc. stock price and the full insider trade history of the company, a listed equity based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was reported on 26 September 2022 (Attribution). Among the most active insiders: Leimkuhler William F.. All data is openly available.
Analysts rate U.S. NeuroSurgical Holdings, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
U.S. NeuroSurgical Holdings, Inc. 是一家专注于神经外科的公司。该公司致力于为医疗专业人员开发和商业化创新的技术和服务。